MapLight Therapeutics, Inc.
Overview
MapLight Therapeutics, Inc. develops neurotechnology solutions focused on neurological and psychiatric disorders through advanced therapeutic approaches. The company leverages innovative technology platforms to advance treatment options in the neuroscience field.
More in Neurotechnology
Latest industry news
Aurenar Raises $5.7M to Push Stroke Neuromodulation Device Toward Market
2026-07-29 · Funding
Neuvotion Brings Brain-Computer and Brain-Body Interface Technologies to Market as Nature Medicine Study Lands
2026-07-28 · Product
FDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD
2026-07-27 · Policy
BRYM Raises €650K to Build Wearable Neurofeedback Platform for Consumer and Clinical Markets
2026-07-26 · Funding
Company details
Category
🏢 Neurotechnology
Funding
Private
Listed
2026-07-10
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →